(Q44585210)

English

Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis

scientific article published in October 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

0 references

author name string

K Bendtzen

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

P R Hansen

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

K Rieneck

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Spironolactone/Arthritis Study Group

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Clinical and Experimental Immunology

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

134

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

151-158

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Effect of spironolactone and its metabolites on contractile property of isolated rat aorta rings

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

Autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

Cytokines and autoimmunity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

Randomized, double-blind trial of anti-interferon-gamma antibodies in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

Human anti-interleukin 1 alpha antibodies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

The metabolism and biopharmaceutics of spironolactone in man.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

Review article: targeting TNF alpha as a key cytokine in the inflammatory processes of Crohn's disease--the mechanisms of action of infliximab

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

Inflammation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

The spironolactone renaissance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808828

27 August 2018

Massive parallel gene expression profiling of RINm5F pancreatic islet beta-cells stimulated with interleukin-1beta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808828

27 August 2018

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808828

27 August 2018

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808828

27 August 2018

Binding of spironolactone metabolites in vivo to renal mineralocorticoid receptors in guinea pigs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808828

27 August 2018

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808828

27 August 2018

Correction of granulocytopenia in Felty's syndrome by granulocyte-macrophage colony-stimulating factor. Simultaneous induction of interleukin-6 release and flare-up of the arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808828

27 August 2018

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

Cytokines in autoimmune disorders

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

Humanized antibody to human interleukin-6 receptor inhibits the development of collagen arthritis in cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

Sandwich ELISA formats designed to detect 17 kDa IL-1 beta significantly underestimate 35 kDa IL-1 beta

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

Preliminary definition of improvement in juvenile arthritis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

Pathogenesis of arthritis: recent research progress

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02249.X

21 January 2018

Inhibition of lipopolysaccharide-induced monocyte interleukin-1 receptor antagonist synthesis by cortisol: involvement of the mineralocorticoid receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/12974768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1046/J.1365-2249.2003.02249.X

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44585210&oldid=2070238701"